Abstract:Background and PurposeMetformin, a small molecule, antihyperglycaemic agent, is a well-known activator of AMP-activated protein kinase (AMPK) and protects against cardiac fibrosis. However, the underlying mechanisms remain elusive. TGF1 is a key cytokine mediating cardiac fibrosis. Here, we investigated the effects of metformin on TGF1 production induced by angiotensin II (AngII) and the underlying mechanisms. Experimental ApproachWild-type and AMPK2(-/-) C57BL/6 mice were injected s.c. with metformin or saline and infused with AngII (3mgkg(-1)day(-1)) for 7days. Adult mouse cardiac fibroblasts (CFs) were isolated for in vitro experiments. Key ResultsIn CFs, metformin inhibited AngII-induced TGF1 expression via AMPK activation. Analysis using bioinformatics predicted a potential hepatocyte nuclear factor 4 (HNF4)-binding site in the promoter region of the Tgfb1 gene. Overexpressing HNF4 increased TGF1 expression in CFs. HNF4 siRNA attenuated AngII-induced TGF1 production and cardiac fibrosis in vitro and in vivo. Metformin inhibited the AngII-induced increases in HNF4 protein expression and binding to the Tgfb1 promoter in CFs. In vivo, metformin blocked the AngII-induced increase in cardiac HNF4 protein levels in wild-type mice but not in AMPK2(-/-) mice. Consequently, metformin inhibited AngII-induced TGF1 production and cardiac fibrosis in wild-type mice but not in AMPK2(-/-) mice. Conclusions and ImplicationsHNF4 mediates AngII-induced TGF1 transcription and cardiac fibrosis. Metformin inhibits AngII-induced HNF4 expression via AMPK activation, thus decreasing TGF1 transcription and cardiac fibrosis. These findings reveal a novel antifibrotic mechanism of action of metformin and identify HNF4 as a new potential therapeutic target for cardiac fibrosis. Linked ArticlesThis article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc

Metformin Attenuates Cardiac Fibrosis by Inhibiting the Tgf Beta(1)-Smad3 Signalling Pathway

Metformin attenuates angiotensin II-induced TGFβ1 expression by targeting hepatocyte nuclear factor-4-α.

Gentiopicroside Alleviates Cardiac Inflammation and Fibrosis in T2DM Rats Through Targeting Smad3 Phosphorylation.

Metformin Inhibits Angiotensin II-induced Differentiation of Cardiac Fibroblasts into Myofibroblasts.

Metformin Attenuates Folic-Acid Induced Renal Fibrosis In Mice

Metformin Attenuates Pressure Overload-Induced Cardiac Hypertrophy Via AMPK Activation

Metformin Attenuates Renal Fibrosis in a Mouse Model of Adenine-Induced Renal Injury Through Inhibiting TGF-β1 Signaling Pathways.

Abstract 17280: Metformin Inhibits Transforming Growth Factor-β1 and Cardiac Fibrosis by Targeting Hepatocyte Nuclear Factor 4Α

The combination of exercise and metformin inhibits TGF-β1/Smad pathway to attenuate myocardial fibrosis in db/db mice by reducing NF-κB–mediated inflammatory response

Metformin is a Novel Suppressor for Transforming Growth Factor (Tgf)-Β1.

Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy

Smad3 Mediates Cardiac Inflammation and Fibrosis in Angiotensin II–Induced Hypertensive Cardiac Remodeling

Metformin Improves Cardiac Function in Rats Via Activation of Amp-Activated Protein Kinase

Metformin Attenuates Cardiac Hypertrophy Via the HIF-1α/PPAR-γ Signaling Pathway in High-Fat Diet Rats

Metformin attenuates renal fibrosis in both AMPKα2-dependent and independent manners.

Metformin Protects Against Systolic Overload–Induced Heart Failure Independent of AMP-Activated Protein Kinase Α2

[Metformin inhibits aortic atherosclerosis in mice by regulating actin skeleton in vascular smooth muscle cells]

Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling

Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy

Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice

Metformin protects the myocardium against isoproterenol-induced injury in rats through alleviating endoplasmic reticulum stress.